fresh no ads
GSK survey reveals over-50s feel younger than their age—but are they overlooking health risks? | Philstar.com
^

Health And Family

GSK survey reveals over-50s feel younger than their age—but are they overlooking health risks?

Philstar.com
for GlaxoSmithKline Philippines
GSK survey reveals over-50s feel younger than their age—but are they overlooking health risks?
'Even if those over 50 feel they are in overall good health, they should not be complacent—our natural ability to fight disease weakens as we get older.'

MANILA, Philippines — GSK plc (LSE/NYSE: GSK) has today released global survey data showing that over half (52%) of people aged 50-60 feel younger than their age—and nearly a fifth (19%) feel as much as a decade younger.1 Despite this positive outlook on healthy ageing, insights from the survey demonstrate a continued lack of awareness of age-related health risks.

The International Federation on Ageing (IFA) has responded by highlighting the need for those aged 50 and over to pay attention to factors that may impact their health and well-being due to a naturally weakened immune system.2

Katrina Bouzanis, acting director of policy, advocacy and innovation at the International Federation on Ageing (IFA), said: “It is wonderful to see such positive attitudes to ageing reported, but the data also shows many over-50s who feel young, happy and healthy and lack awareness of their risk of age-related diseases like shingles.

“Even if those over 50 feel they are in overall good health, they should not be complacent—our natural ability to fight disease weakens as we get older. We need to ensure people understand this fully so that they can take better care of their health as they age.” 

By 50, most carry the varicella-zoster virus (VZV), the same virus that causes chickenpox, which may lie dormant and reactivate as the immune system weakens over time.
Fictional patient, for illustrative purposes only

The survey of 8,400 participants from nine countries examined 50- to 60-year-olds’ perception of healthy ageing and the related risk of shingles.1

The findings, published at the start of Shingles Awareness Week (February 24 – March 2, 2025), highlight limited understanding of this age group’s susceptibility to age-related risks—with over one-third (37%) of those who feel younger admitting they have “no concern” about their chances of developing shingles.1

Globally, one in three adults will develop this disease in their lifetime.2,3,4,5

Over half (55%) are unaware that having long-term health issues such as diabetes, cardiovascular disease, chronic obstructive pulmonary disease (COPD) and chronic kidney disease can weaken immunity.1,6

The survey data also demonstrates that among those who have chronic medical conditions, a third (33%) expressed having no concerns about developing shingles at all or that they didn’t know whether to be concerned.1

Fictional patient, for illustrative purposes only

Shingles risk in the Philippines

While the Philippines was not included in the survey, its findings are highly relevant given the country’s aging population and the growing burden of chronic diseases. With over 18.9 million Filipino ages 50 and above7, the risk of shingles remains a concern. The highest incidence of shingles is observed in adults aged 50 to 59, with around 2 million Filipinos, or 24%, at risk.6

Dr. Gio Barangan, country medical director of GSK Philippines, explains: “The survey underscores a global trend where many adults over 50 feel youthful and healthy but remain unaware of the health risks that come with ageing. While this study was conducted in other countries, the same applies to Filipinos, given the high prevalence of diabetes,8 hypertension9 and cardiovascular diseases10—conditions that weaken the immune system and increase the risk of shingles.6

“As we mark Shingles Awareness Week, it’s crucial to bridge these knowledge gaps. We encourage individuals aged 50 and older, especially those with chronic conditions, to have informed discussions with their healthcare providers about their personal risk.”

For many older adults, shingles becomes more likely with age. By 50, most carry the varicella-zoster virus (VZV)5, the same virus that causes chickenpox, which may lie dormant and reactivate as the immune system weakens over time.5

Stress2, along with chronic conditions such as lung and cardiovascular diseases4, can contribute to weakening immunity over time and increase the risk of shingles. In fact, one in three people worldwide is expected to experience it during their lifetime. 5

Shingles is not just painful—it can cause intense nerve pain that leaves people feeling isolated, helpless and depressed,11 severely impacting daily life and your ability to do your work ability.12 While its most common complication is long-lasting nerve pain known as postherpetic neuralgia, shingles can also lead to vision loss, scarring and an increased risk of stroke.13

By increasing awareness of shingles and its potential impact, Shingles Awareness Week 2025 aims to empower more Filipinos to take proactive steps toward better health as they age. Protecting yourself starts with awareness—talk to your doctor to understand your risk and learn more about shingles treatment and prevention.

Visit https://whatisshingles.ph/ to know more about shingles.
 
For Philippine audience only.
For further information, consult your doctor. 
A Health Service message brought to you by GSK.
To report adverse events, please email: ph.safety@gsk.com
 
©2025 GSK group of companies or its licensor
GlaxoSmithKline Philippines Inc.
GSK Address: 23rd Floor, The Finance Centre, 26th Street corner 9th Avenue, Bonifacio Global City, Taguig City, Metro Manila 1634
NP-PH-HZU-ADVR-250002 | March 2025
 
References:
 
IPSOS on behalf of GSK. Shingles Awareness Week Survey. Data on file. 2025.Han R. et. al., (2022, November 23) Public Health Impact of Introducing an Adjuvanted Recombinant Zoster Vaccine in the Philippines [Poster Presentation]. 44th PSMID Annual Convention, Manila, Philippines.
Harpaz, R., et al. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57(Rr-5):1-30;
Shingles in Australia. Australian Institute of Health and Welfare [Available from: https://www.aihw.gov.au/getmedia/759199ff-f5c8-421d-a572-aaa984a02b49/aihw-phe-236_shingles.pdf.aspx Last Accessed: February 2025]
Curran, D., et al. Meta-Regression of Herpes Zoster Incidence Worldwide. Infectious diseases and therapy. 2022;11(1):389-403.
Lee, C., et al. Lifetime risk of herpes zoster in the population of Beijing, China. Public health in practice (Oxford, England). 2023;5:100356.
Steinmann M, et al. Infection. 2024;52(3):1009–1026.                                 
Han R. et. al., (2022, November 23) Public Health Impact of Introducing an Adjuvanted Recombinant Zoster Vaccine in the Philippines [Poster Presentation]. 44th PSMID Annual Convention, Manila, Philippines.
Cando LFT, Quebral EPB, Ong EP, Catral CDM, Relador RJL, Velasco AJD, Alcazar RMU, Reyes NAL, Pilotin EJB, Ornos EDB, Paz-Pacheco E, Tantengco OAG. Current status of diabetes mellitus care and management in the Philippines. Diabetes Metab Syndr. 2024 Feb;18(2):102951. doi: 10.1016/j.dsx.2024.102951. Epub 2024 Feb 8. PMID: 38382166. https://pubmed.ncbi.nlm.nih.gov/38382166/
Sison, J. A. (2023, June 27). An overview of the presyon 4 trial and its impact on practice. Radcliffe Cardiology. https://www.japscjournal.com/articles/overview-presyon-4-trial-and-its-impact-practice
10 Corpuz, J. (2024, March). Cardiovascular disease in the Philippines: A new public health emergency? Journal of Public Health. https://academic.oup.com/jpubhealth/article/46/1/e203/7261455
11 Weinke T, Edte A, Schmitt S, Lukas K. Impact of herpes zoster and post-herpetic neuralgia on patients’ quality of life: a patient-reported outcomes survey. Z Gesundh Wiss. 2010;18:367–374.
12 Gater, A., Uhart, M., & McCool, R. (2015b, February 27). The humanistic, economic and societal burden of Herpes Zoster in Europe: A critical review - BMC public health. BioMed Central. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-015-1514-y
13 Erskine N, Tran H, Levin L, et al. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PloS One. 2017;12:e0181565.
 

Editor’s Note: This press release is sponsored by GlaxoSmithKline Philippines. It is published by the Advertising Content Team that is independent from our Editorial Newsroom.


 

ELDERLY NEEDS

GLAXOSMITHKLINE

SHINGLES

Philstar
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with